Albert Einstein College of Medicine of Yeshiva University, a division of Yeshiva University
Patent Applications and Registrations
Patent applications and USPTO patent grants for Albert Einstein College of Medicine of Yeshiva University, a division of Yeshiva University.The latest application filed is for "chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers".
- Albert Einstein College of Medicine of Yeshiva University, a division of Yeshiva University - Bronx NY
| Patent | Date |
|---|---|
| Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers App 20040158885 - Rogler, Charles E. ; et al. | 2004-08-12 |
| Mouse telomerase reverse transcriptase Grant 6,767,719 - Morin , et al. July 27, 2 | 2004-07-27 |
| Proliferation of hepatocyte precursors Grant 6,146,889 - Reid , et al. November 14, 2 | 2000-11-14 |
| Nucleic acid encoding rhodococcus phenylalanine dehydrogenase Grant 5,851,810 - Blanchard December 22, 1 | 1998-12-22 |
| Method and compounds for inhibiting lipid biosynthesis of bacteria and plants Grant 5,837,480 - Sacchettini , et al. November 17, 1 | 1998-11-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 